Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06640803 · ClinicalTrials.gov registry record · NA
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
A NA study of Clinical High Risk for Psychosis and Ultra High Risk for Psychosis, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 223
- Enrollment target
- 6
- Study locations
NCT06640803: Recruiting NA study of Clinical High Risk for Psychosis and Ultra High Risk for Psychosis, sponsored by University of California, Davis.
NCT06640803 is a NA study of Clinical High Risk for Psychosis and Ultra High Risk for Psychosis that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 223 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06640803, a NA study of Clinical High Risk for Psychosis and Ultra High Risk for Psychosis, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 223 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for psychosis within multiple community mental health centers.
Primary Outcome
1\. Duration of enrollment in the stepped-care intervention for young people identified as at clinical high-risk for psychosis through their community health setting.
Conditions Studied
Interventions
- BEHAVIORAL Stepped-Care including Cognitive Behavioral Case Management
Study Locations (6)
California
- River Oak Center for Children - Elk Grove
- Turning Point Community Programs - Elk Grove
- University of California Department of Psychiatry and Behavioral Sciences; Early Psychosis Programs - Sacramento
- University of California-Davis CAARE Diagnostic and Treatment Center - Sacramento
- Capital Star Community Services - Sacramento
- Heartland Child and Family Services - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2023-03-20 |
| Est. Completion | 2026-10-01 |
| Phase | NA |
What NCT06640803 shows while recruiting
NCT06640803 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Clinical High Risk for Psychosis appearing as the primary indexed condition, and to 1 intervention - of which Stepped-Care including Cognitive Behavioral Case Management is the first listed.
NCT06640803 lists 6 locations in 1 state (California).
Frequently Asked Questions
What is clinical trial NCT06640803 about?
NCT06640803 is a clinical study titled "Sacramento Clinical High Risk for Psychosis Stepped-Care Program". This is a dissemination and implementation study that is evaluating a stepped-care intervention for identifying and treating youths at clinical high-risk for psychosis within multiple community mental health centers.
What is the current status of trial NCT06640803?
This trial is currently recruiting. It is a NA study. The enrollment target is 223 participants. The study started on 2023-03-20. Estimated completion is 2026-10-01.
What conditions does trial NCT06640803 study?
This clinical trial studies the following conditions: Clinical High Risk for Psychosis, Ultra High Risk for Psychosis.
What interventions are being tested in trial NCT06640803?
The interventions under investigation include: Stepped-Care including Cognitive Behavioral Case Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06640803?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06640803 being conducted?
This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Clinical High Risk for Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06640803's enrollment target sits among peer trials
223 481st of 2000 higher than 1,520 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07175285 · 223 participants
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- NCT07205718 · 223 participants · Phase 1
A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors
- NCT02706561 · 224 participants · NA
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
- NCT04140344 · 224 participants · NA
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI